These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 30890477)

  • 21. Association of FOXP3 (rs3761548) promoter polymorphism with nondermatomal vitiligo: A study from India.
    Jahan P; Cheruvu R; Tippisetty S; Komaravalli PL; Valluri V; Ishaq M
    J Am Acad Dermatol; 2013 Aug; 69(2):262-6. PubMed ID: 23498308
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of allelic variants in the catalase gene in patients with the skin depigmenting disorder vitiligo.
    Gavalas NG; Akhtar S; Gawkrodger DJ; Watson PF; Weetman AP; Kemp EH
    Biochem Biophys Res Commun; 2006 Jul; 345(4):1586-91. PubMed ID: 16729966
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic polymorphisms in CDH1 and Exo1 genes elevate the prostate cancer risk in Bangladeshi population.
    Imtiaz H; Afroz S; Hossain MA; Bellah SF; Rahman MM; Kadir MS; Sultana R; Mazid MA; Rahman MM
    Tumour Biol; 2019 Mar; 41(3):1010428319830837. PubMed ID: 30880589
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of CDH1 single nucleotide polymorphisms with susceptibility to esophageal squamous cell carcinomas and gastric cardia carcinomas.
    Zhang XF; Wang YM; Ge H; Cao YY; Chen ZF; Wen DG; Guo W; Wang N; Li Y; Zhang JH
    Dis Esophagus; 2008; 21(1):21-9. PubMed ID: 18197935
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of a microsatellite polymorphism of the cytotoxic T-lymphocyte antigen-4 gene in patients with vitiligo.
    Kemp EH; Ajjan RA; Waterman EA; Gawkrodger DJ; Cork MJ; Watson PF; Weetman AP
    Br J Dermatol; 1999 Jan; 140(1):73-8. PubMed ID: 10215771
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Single-nucleotide polymorphisms of APE1 associated with risk and prognosis of vitiligo in a Han Chinese population.
    Chen XJ; Chang LL; Wang Q; Han CY; Li WJ; Tian FJ; Liu LQ
    Adv Clin Exp Med; 2019 Sep; 28(9):1249-1255. PubMed ID: 31430071
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation of increased MYG1 expression and its promoter polymorphism with disease progression and higher susceptibility in vitiligo patients.
    Dwivedi M; Laddha NC; Begum R
    J Dermatol Sci; 2013 Sep; 71(3):195-202. PubMed ID: 23706493
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic association of NALP1 with generalized vitiligo in Jordanian Arabs.
    Alkhateeb A; Qarqaz F
    Arch Dermatol Res; 2010 Oct; 302(8):631-4. PubMed ID: 20574744
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inducible nitric oxide synthase promoter polymorphism: a molecular susceptibility marker for vitiligo in Egyptians.
    Zayed AA; Khorshied MM; Hussein MF
    Int J Dermatol; 2015 Jun; 54(6):675-9. PubMed ID: 25556582
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CTLA4 polymorphisms are associated with vitiligo, in patients with concomitant autoimmune diseases.
    Blomhoff A; Kemp EH; Gawkrodger DJ; Weetman AP; Husebye ES; Akselsen HE; Lie BA; Undlien DE
    Pigment Cell Res; 2005 Feb; 18(1):55-8. PubMed ID: 15649153
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between CDH1 haplotypes and gastric cancer risk in a Japanese population.
    Yamada H; Shinmura K; Ikeda S; Tao H; Otani T; Hanaoka T; Tsuneyoshi T; Tsugane S; Sugimura H
    Scand J Gastroenterol; 2007 Dec; 42(12):1479-85. PubMed ID: 17852867
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Association between single nucleotide polymorphisms of BARD 1 gene and susceptibility of early-onset breast cancer in Uygur women in Xinjiang].
    Sun G; Wang JT; Ma BL; Geng ZL; Ren GH; Shan MH; Ma B; Ma LL; Wang Y
    Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):341-7. PubMed ID: 22883453
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of clinicopathological features with E-cadherin (CDH1) gene-160 C>A promoter polymorphism in Turkish colorectal cancer patients.
    Bahadir A; Eral G; Budak M; Shimamoto F; Korpinar MA; Erdamar S; Tuncel H
    J Cancer Res Ther; 2019; 15(1):26-31. PubMed ID: 30880750
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Catalase -262C>T polymorphisms in Hungarian vitiligo patients and in controls: further acatalasemia mutations in Hungary.
    Kósa Z; Fejes Z; Nagy T; Csordás M; Simics E; Remenyik E; Góth L
    Mol Biol Rep; 2012 Apr; 39(4):4787-95. PubMed ID: 21947853
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PTPN22 is genetically associated with risk of generalized vitiligo, but CTLA4 is not.
    LaBerge GS; Bennett DC; Fain PR; Spritz RA
    J Invest Dermatol; 2008 Jul; 128(7):1757-62. PubMed ID: 18200060
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Correlation of E-cadherin polymorphisms to esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma].
    Zhang XF; Wang YM; Wang R; Wei LZ; Li Y; Guo W; Wang N; Zhang JH
    Ai Zheng; 2005 May; 24(5):513-9. PubMed ID: 15890089
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discoidin domain receptor 1 gene variants are associated with decreased white matter fractional anisotropy and decreased processing speed in schizophrenia.
    Gas C; Canales-Rodríguez EJ; Radua J; Abasolo N; Cortés MJ; Salvadó E; Muntané G; Alemán-Gómez Y; Julià T; Marsal S; Sanjuan J; Guitart M; Costas J; Martorell L; Pomarol-Clotet E; Vilella E
    J Psychiatr Res; 2019 Mar; 110():74-82. PubMed ID: 30597424
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of e-cadherin gene CDH1 polymorphism -160 C/A with susceptibility to develop vitiligo.
    Kubelis-López DE; Zapata-Salazar NA; Salinas-Santander MA; Sánchez-Domínguez CN; Morlett-Chávez JA; Ocampo-Candiani J
    An Bras Dermatol; 2023; 98(3):376-378. PubMed ID: 36754648
    [No Abstract]   [Full Text] [Related]  

  • 39. Association between
    Agwa SHA; Kamel MM; Elghazaly H; Abd Elsamee AM; Hafez H; Girgis SA; Ezz Elarab H; Ebeid FSE; Sayed SM; Sherif L; Matboli M
    Genes (Basel); 2021 May; 12(6):. PubMed ID: 34071309
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lack of association with TNF-alpha-308 promoter polymorphism in patients with vitiligo.
    Yazici AC; Erdal ME; Kaya TI; Ikizoglu G; Savasoglu K; Camdeviren H; Tursen U
    Arch Dermatol Res; 2006 Jun; 298(1):46-9. PubMed ID: 16691430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.